A disorder caused by the infection in Lyme disease and manifesting after the original infection.
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 7, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 7, 2026
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 7, 2026
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning post-treatment Lyme disease syndrome
Updated Feb 2, 2026
En Carta Diagnostics' EC Pocket Lyme test has received FDA Breakthrough Device Designation, aiming to improve diagnosis for the approximately 476,000 new Lyme disease cases reported annually in the US. This designation may expedite the test's development and review process.
Clinical trials for new Lyme disease vaccines are currently underway, but no vaccine is available yet. This highlights ongoing efforts to address Lyme disease prevention amid rising cases.
The CDC highlights Lyme Disease Awareness Month, urging Americans to educate themselves about this tickborne disease. The campaign aims to promote protective measures for those in areas with Lyme disease activity.
The CDC reports that Lyme disease cases have more than doubled since 1991, highlighting a significant public health concern. Notably, 93% of these cases are concentrated in just 10 states, emphasizing the need for targeted awareness and prevention efforts.